Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,603 across all filing types
Latest filing 2025-06-09 Governance Information
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
List of Directors and Their Role and Function
Governance Information Classification · 82% confidence The document is an official announcement filed with the Hong Kong Exchange listing the company’s board members, their roles (executive, non-executive, independent), and detailed board committee memberships. It is not an AGM notice, voting result, earnings release, or capital update, nor is it merely a publication notice. Rather, it is a governance report detailing board structure and committee composition – fitting the Governance Information category.
2025-06-09 English
ANNOUNCEMENT PROPOSED CHANGE OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 98% confidence The document is a corporate announcement on the Hong Kong Stock Exchange about the resignation and proposed appointment of non-executive directors. It details changes in board composition, biographies of the incoming director, and compliance with listing rules. This clearly falls under changes in the company’s board/management rather than a full annual report, earnings release, or other category.
2025-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings Classification · 87% confidence The document is a routine monthly return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised/registered share capital and issued shares. It is not an earnings release, M&A announcement, or financial report like a 10-K or interim report. Nor does it announce a specific transaction such as a share buyback or new issuance. It is a standard regulatory submission without fitting any specialized category. Therefore it falls under the fallback “Regulatory Filings” category.
2025-06-05 English
FORM OF PROXY FOR DOMESTIC SHAREHOLDERS' CLASS MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a form of proxy for domestic shareholders’ class meeting, used by the company to solicit votes and authorize proxies for a shareholder meeting. This is classic Proxy Solicitation & Information Statement material rather than an annual report, earnings release, or other regulatory notice. Therefore, it fits category 24: PSI.
2025-05-22 English
FORM OF PROXY FOR H SHAREHOLDERS' CLASS MEETING
Proxy Solicitation & Information Statement Classification · 88% confidence The document is a ‘Form of Proxy’ for an H Shareholders’ Class Meeting, providing voting instructions and details for appointing a proxy to attend and vote at the meeting. This is part of materials sent to shareholders to solicit votes, which falls under Proxy Solicitation & Information Statement (PSI).
2025-05-22 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled “Form of Proxy for Annual General Meeting” and provides shareholders with a proxy appointment form and voting instructions for the upcoming AGM. It is a materials packet sent to shareholders to solicit votes rather than the meeting presentation itself or the actual AGM minutes. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2025-05-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.